Cargando…
Sulfadiazine analogs: anti-Toxoplasma in vitro study of sulfonamide triazoles
Toxoplasmosis is an infection that prevails all over the world and is caused by the obligate intracellular protozoan parasite Toxoplasma gondii (T. gondii). Promising novel compounds for the treatment of T. gondii are introduced in the current investigation. In order to test their in vitro potency a...
Autores principales: | Arafa, Fadwa M, Osman, Doaa Hassan, Tolba, Mona Mohamed, Rezki, Nadjet, Aouad, Mohamed R, Hagar, Mohamed, Osman, Mervat, Said, Heba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495491/ https://www.ncbi.nlm.nih.gov/pubmed/37610452 http://dx.doi.org/10.1007/s00436-023-07936-x |
Ejemplares similares
-
Nanoformulation-Based 1,2,3-Triazole Sulfonamides for Anti-Toxoplasma In Vitro Study
por: Arafa, Fadwa M., et al.
Publicado: (2023) -
Synthesis, Characterization and Nanoformulation of Novel Sulfonamide-1,2,3-triazole Molecular Conjugates as Potent Antiparasitic Agents
por: Aljohani, Faizah S., et al.
Publicado: (2022) -
Design, Synthesis, Molecular Modeling, Anticancer
Studies, and Density Functional Theory Calculations of 4-(1,2,4-Triazol-3-ylsulfanylmethyl)-1,2,3-triazole
Derivatives
por: Al Sheikh Ali, Adeeb, et al.
Publicado: (2020) -
Novel 1,2,3-Triazole-sulphadiazine-ZnO Hybrids as Potent Antimicrobial Agents against Carbapenem Resistant Bacteria
por: Aljohani, Faizah S., et al.
Publicado: (2022) -
1,2,3-Triazole-Benzofused Molecular Conjugates as Potential Antiviral Agents against SARS-CoV-2 Virus Variants
por: Al-Humaidi, Jehan Y., et al.
Publicado: (2022)